###begin article-title 0
Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes
###end article-title 0
###begin p 1
Conceived and designed the experiments: JS JB. Performed the experiments: JS JL AK JB. Analyzed the data: JS JL AK RN PN SM MK JT JB. Contributed reagents/materials/analysis tools: JS AH JB. Wrote the paper: JS JB.
###end p 1
###begin p 2
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 508 511 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apo</italic>
###xml 511 518 511 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 522 531 522 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
Despite the well-documented effects of plasma lipid lowering regimes halting atherosclerosis lesion development and reducing morbidity and mortality of coronary artery disease and stroke, the transcriptional response in the atherosclerotic lesion mediating these beneficial effects has not yet been carefully investigated. We performed transcriptional profiling at 10-week intervals in atherosclerosis-prone mice with human-like hypercholesterolemia and a genetic switch to lower plasma lipoproteins (Ldlr-/-Apo100/100Mttpflox/flox Mx1-Cre). Atherosclerotic lesions progressed slowly at first, then expanded rapidly, and plateaued after advanced lesions formed. Analysis of lesion expression profiles indicated that accumulation of lipid-poor macrophages reached a point that led to the rapid expansion phase with accelerated foam-cell formation and inflammation, an interpretation supported by lesion histology. Genetic lowering of plasma cholesterol (e.g., lipoproteins) at this point all together prevented the formation of advanced plaques and parallel transcriptional profiling of the atherosclerotic arterial wall identified 37 cholesterol-responsive genes mediating this effect. Validation by siRNA-inhibition in macrophages incubated with acetylated-LDL revealed a network of eight cholesterol-responsive atherosclerosis genes regulating cholesterol-ester accumulation. Taken together, we have identified a network of atherosclerosis genes that in response to plasma cholesterol-lowering prevents the formation of advanced plaques. This network should be of interest for the development of novel atherosclerosis therapies.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
Atherosclerosis is present in the major arteries of all adults. In industrial societies, atherosclerosis progression in approximately50% of adults leads to clinical manifestations such as stroke and myocardial infarction, and eventually death. Lowering circulating LDL-cholesterol levels can slow atherosclerosis progression and even cause regression. Yet, little is known about the genes in the atherosclerotic arterial wall that mediate those effects. To identify such genes, we studied genetically modified mice in which high levels of human-like LDL-cholesterol cause rapid progression of atherosclerosis; the mice also had a genetic "switch" to lower LDL-cholesterol. Lowering LDL-cholesterol at a critical point before advanced plaques developed stopped lesion progression. Analysis of gene expression in response to the lowering of plasma LDL-cholesterol revealed 37 lesion genes as possible mediators of this effect. We validated some of these genes in macrophages using siRNA incubated with acetylated-LDL to mimic foam cells, which are central to atherosclerosis progression. "Reverse engineering" of whole-genome expression data from these experiments revealed a regulatory gene network of cholesterol-responsive atherosclerosis genes that control foam cell formation. This network and the individual genes within it merit further attention as targets for drugs to prevent the transformation of early harmless lesions into advanced, clinically significant plaques.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Ong1">[1]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Grines1">[2]</xref>
###xml 560 563 560 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tuomisto1">[3]</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Venter1">[4]</xref>
###xml 647 650 647 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Lander1">[5]</xref>
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Waterston1">[6]</xref>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 879 882 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apo</italic>
###xml 885 892 885 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 896 905 896 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 909 912 909 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 925 928 925 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Lieu1">[7]</xref>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 1021 1024 1021 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 1028 1035 1028 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 1140 1144 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 1144 1153 1144 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 1157 1160 1157 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 913 918 <span type="species:ncbi:10090">mouse</span>
Atherosclerosis is a lifelong, progressive disease that becomes clinically significant in 50% of the population, leading to myocardial infarction (MI), stroke, and eventually death. Statin-based lipid-lowering regimens reduce morbidity and mortality from both MI and stroke [1]. Aggressive statin regimens can even cause regression of atherosclerosis [2] but sometimes generate severe side effects. To fully exploit the beneficial effects of lipid lowering, we need a better understanding of the transcriptional changes induced by lowering plasma lipoproteins [3]. Whole-genome measurement technologies developed in the aftermath of the human [4],[5] and mouse [6] genome projects offer the opportunity to uncover entire repertoires of changes in gene expression related to complex diseases like atherosclerosis and reveal their interplay in regulatory networks. We used the Ldlr-/-Apo100/100Mttpflox/floxMx1-Cre mouse model [7] that has a plasma lipoprotein profile similar to that of familial hypercholesterolemia (Ldlr-/-Apob100/100) and a genetic switch to block hepatic synthesis of lipoproteins and thereby lower plasma lipoproteins (Mttpflox/floxMx1-Cre) to investigate the effects of plasma cholesterol-lowering on atherosclerosis development and to identify cholesterol-responsive atherosclerosis genes.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Basic Characteristic and Atherosclerotic Lesion Development
###end title 8
###begin p 9
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 148 155 148 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 144 159 144 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup>Mttp</italic>
###xml 159 168 159 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 182 194 182 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A&#8211;1C</xref>
###xml 406 407 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 466 467 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 806 822 782 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A and 1B</xref>
###xml 1008 1017 984 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1C</xref>
###xml 1130 1137 1106 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000036-t001">Table 1</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
The mice were sacrificed at 10, 20, 30, 40, 50 and 60 weeks of age. Lesion area and morphological changes were assessed in a total of 87 Ldlr-/-Apob100/100Mttpflox/floxMx1-Cre mice (Figure 1A-1C). Only occasional spots of Sudan IV staining were detected at 10 weeks (n = 10, not shown), but lesions were detected in all mice at 20 weeks. Lesion size increased by approximately1.6% between weeks 20 and 30 (P = 0.05) and by approximately7.2% between weeks 30 and 40 (P<0.0001). At 20 weeks, the main morphological feature was fatty streaks (red transparent areas with diffuse boundaries); no plaques were detected. At 30 weeks, all mice had small plaques (red nontransparent areas with distinct boundaries) in the aortic arch that had expanded markedly at 40 weeks. Thereafter plaque growth was restrained (Figure 1A and 1B). The area of Oil-red-O staining in the aortic root followed a similar progression curve as the Sudan IV lesion staining whereas CD68 staining increased sharply between week 20 and 30 (Figure 1C). Plasma cholesterol increased slightly with age whereas plasma triglyceride and glucose levels were unchanged (Table 1).
###end p 9
###begin title 10
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 42 49 42 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 38 54 38 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup> Mttp</italic>
###xml 54 63 54 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Atherosclerosis progression in Ldlr-/-Apob100/100 Mttpflox/flox mice.
###end title 10
###begin p 11
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 380 382 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 440 442 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 449 451 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
(A) Box plots of atherosclerosis progression at 20 (n = 12), 30 (n = 25), 40 (n = 15), 50 (n = 15), and 60 weeks (n = 10). P<0.05, 20 vs. 30 weeks; P<0.0001, 30 vs. 40 weeks; P<0.02, 40 vs. 50 weeks. Values are surface lesion areas assessed by Sudan IV staining of pinned-out aortas and given as a percentage of the surface of the entire aorta. Boxes enclose values between the 75th and 25th percentiles, bars indicate values between the 90th and 10th percentiles, and black dots indicate individual observations outside these boundaries. (B) Representative aortic trees (above) and arches (below). (C) Representative sections of the aortic root were stained with Oil-red-O and counterstained with hematoxylin (Htx) or show CD68 fluorescence and counterstained with DAPI.
###end p 11
###begin title 12
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 90 97 90 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 86 101 86 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup>Mttp</italic>
###xml 101 110 101 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Plasma cholesterol, triglyceride, and glucose concentrations of representative Ldlr-/-Apob100/100Mttpflox/floxMx1-Cre mice.
###end title 12
###begin p 13
###xml 96 97 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Values are mean +/-SD. There were no statistically significant differences between time points (P>0.05).
###end p 13
###begin title 14
Transcriptional Profiling of Lesion Development
###end title 14
###begin p 15
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Efron1">[8]</xref>
###xml 384 392 384 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s002">Table S1</xref>
###xml 447 455 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s007">Table S6</xref>
###xml 138 143 <span type="species:ncbi:10090">Mouse</span>
Next, we identified transcriptional changes of atherosclerosis development using 32 cDNA arrays (5 to 7 per time point). Of 19,879 genes (Mouse Genome Informatics Database, ), 1259 (6.3%) were differentially expressed according to empirical Bayes statistics [8] at one or more time comparisons (FDR<0.05, n = 1259). Of these, 329 (27%) had previously been related to atherosclerosis (Table S1). Of genes with established roles in atherosclerosis (Table S6), 78% (88/111) were among the differentially expressed genes.
###end p 15
###begin p 16
###xml 111 120 111 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 122 131 122 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s022">Table S21</xref>
###xml 160 168 160 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s009">Table S8</xref>
###xml 240 249 240 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A</xref>
###xml 287 296 287 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 423 432 423 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 434 442 434 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s002">Table S1</xref>
###xml 502 512 502 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s014">Tables S13</xref>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s018">S17</xref>
###xml 519 522 519 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s023">S22</xref>
Cluster analysis of mRNA levels of differentially expressed genes (n = 1259) generated four distinct clusters (Figure 2A, Table S21). Cluster 1 genes (n = 293, Table S8) were activated during rapid lesion expansion between 30 and 40 weeks (Figure 1A) and remained activated at 60 weeks (Figure 2A). This cluster had the highest percentage (36%) of genes previously related to atherosclerosis or atherosclerosis cell types (Figure 2A, Table S1), and 89% of the genes were related to inflammatory cells (Tables S13, S17, S22).
###end p 16
###begin title 17
Transcriptional changes of atherosclerosis development.
###end title 17
###begin p 18
###xml 421 429 421 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s002">Table S1</xref>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s003">Tables S2</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s004">S3</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s005">S4</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s006">S5</xref>
###xml 615 624 615 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s001">Figure S1</xref>
###xml 901 909 901 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s008">Table S7</xref>
###xml 1100 1101 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
(A) Heat map of clustered mRNA levels (rows; red, high levels; blue, low levels) for genes differentially expressed (d.e.) in at least one pair-wise time-point comparison (FDR<0.05, n = 1259). Each column represents mRNA levels in one mouse (n = 5 to 7 per time point) at 10 to 60 weeks of age. Four gene clusters were identified by the cluster algorithm. Pie charts show percentages of genes related to atherosclerosis (Table S1) on the left and to the four atherosclerosis cell types (Tables S2, S3, S4, and S5) on the right. A substantial number of genes were related to more than one atherosclerosis cell type (Figure S1). The percentage of novel genes (i.e., not related to atherosclerosis or atherosclerosis cell types) in each cluster is shown on the far right. Overall percentages (total) are shown below. (B) Relative expression levels of cell-specific markers of atherosclerosis cell types (Table S7). The number of markers per cell type is indicated. The only statistically significant increase was in the number of foam cells, which increased by approximately30% between 20 and 30 weeks (P<0.001) and remained elevated at 60 weeks. (C) Representative sections of the aortic root (top) were stained with Oil-red-O (red in the figure) and counterstained with hematoxylin (Htx) (blue spots in the figure), bar in figure indicate 50 microm; higher-power views of 50 microm showing foam cells at 30 (arrows indicate macrophage Htx-stained nuclei, asterisk marked arrows point to the outer cell membrane) and 40 weeks (asterisk marked arrows point to the outer cell membrane of Oil-red-O-stained fat within macrophages, the nuclei are not visible) are shown below.
###end p 18
###begin p 19
###xml 57 65 57 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s010">Table S9</xref>
###xml 105 114 105 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s012">Table S11</xref>
###xml 167 176 167 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 258 268 258 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s015">Tables S14</xref>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s017">S16</xref>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s019">S18</xref>
###xml 280 283 280 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s021">S20</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s024">S23</xref>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s026">S25</xref>
Gene activities peaked at week 30 in cluster 2 (n = 331; Table S9) and at week 40 in cluster 4 (n = 300; Table S11) and were suppressed at late stages of progression (Figure 2A); 73% had no previous relation to atherosclerosis or atherosclerosis cell types (Tables S14, S16, S18, S20, S23, and S25).
###end p 19
###begin p 20
###xml 20 29 20 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s011">Table S10</xref>
###xml 151 160 151 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 385 395 385 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s016">Tables S15</xref>
###xml 397 400 397 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s020">S19</xref>
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s025">S24</xref>
Cluster 3 (n = 339; Table S10) was particularly interesting because the mRNA levels of these genes peaked at 30 weeks and were suppressed at 40 weeks (Figure 2A), coinciding with the rapid lesion expansion phase. This cluster had fewer atherosclerosis-related genes than cluster 1 but more than clusters 2 or 4 and consisted mainly of genes related to carboxylic and lipid metabolism (Tables S15, S19, and S24). Thirteen of 19 TFs are well-established in lipid and energy metabolism, including the peroxisome proliferator activator receptors (PPARs; Ppara (Entrez Gene ID 19013), Ppard (Entrez Gene ID 19015), and Pparg (Entrez Gene ID 19016)) and sterol regulatory element binding factor 2 (Srebf2, Entrez Gene ID 20788), which also have been implicated in the regulation of foam-cell formation.
###end p 20
###begin p 21
###xml 28 36 28 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s008">Table S7</xref>
###xml 322 331 322 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2B</xref>
###xml 457 466 457 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2B</xref>
###xml 563 572 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1C</xref>
Cell-type-specific markers (Table S7) were used to investigate changes to the relative cell type contents of the lesion over time. mRNA levels of these markers on the GeneChips indicated that most of the major lesion cell types (smooth muscle and endothelial and T-cells) were relatively stable during lesion progression (Figure 2B). In contrast, macrophages/foam cells increased in number between 20 and 30 weeks and remained at this level until 60 weeks (Figure 2B). This change in lesion macrophage number confirmed the notion obtained from the CD68 staining (Figure 1C).
###end p 21
###begin p 22
###xml 158 167 158 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2B</xref>
###xml 205 214 205 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 332 348 332 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A and 1B</xref>
###xml 418 427 418 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 489 498 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
In summary, the gene expression data suggest that macrophages gradually accumulate in the early phases of lesion development, reaching a density at 30 weeks (Figure 2B), inducing an inflammatory reaction (Figure 2A, cluster 1), increasing lipid accumulation in foam cells (Figure 2A, cluster 3), and causing rapid lesion expansion (Figure 1A and 1B). The lipid accumulation in foam cells was sustained until 40 weeks (Figure 2A, cluster 3). The inflammation persisted in the later phases (Figure 2A, cluster 1).
###end p 22
###begin p 23
###xml 215 224 215 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2C</xref>
This interpretation of the expression data was supported by a immunohistochemical examination showing that lipid-poor macrophages had accumulated at 30 weeks and then had expanded and become lipid-rich at 40 weeks (Figure 2C).
###end p 23
###begin title 24
Identification of Plasma Cholesterol-Responsive Atherosclerosis Genes
###end title 24
###begin p 25
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 200 207 200 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 196 211 196 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup>Mttp</italic>
###xml 211 222 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 478 487 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3A</xref>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
To investigate the role of plasma cholesterol in causing the rapid lesion expansion between week 30 and 40, we genetically lowered plasma LDL cholesterol by inducing recombination of Mttp (Ldlr-/-Apob100/100MttpDelta/Delta) in 30-week-old mice. Plasma cholesterol was reduced >80% (427 to 54+/-31 mg/L, n = 6) and remained at this level for 10 weeks until sacrifice. At sacrifice, lesion size had not increased and was significantly less than in controls with high cholesterol (Figure 3A). Lesion histology was indistinguishable from that in 30-week-old mice with high plasma cholesterol (not shown). Thus, lowering plasma cholesterol at 30 weeks eliminated the formation of advanced plaques observed in mice with sustained high levels of plasma cholesterol.
###end p 25
###begin title 26
Effect of plasma-cholesterol lowering on lesion progression.
###end title 26
###begin p 27
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 655 656 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A</xref>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 910 919 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g001">Figure 1A</xref>
###xml 1022 1023 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1052 1053 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1084 1085 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1114 1115 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 1198 1201 <span type="species:ncbi:10116">rat</span>
###xml 1224 1227 <span type="species:ncbi:10116">rat</span>
###xml 1233 1238 <span type="species:ncbi:10090">mouse</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
Lesion surface area was determined as the percentage of lesion area in relation to the total area of pinned-out aortas from the bifurcation to the aortic root. At 28 weeks of age, mice received intraperitoneal injections of pI-pC to induce recombination of Mttp in the liver and were sacrificed 12 weeks later or 1 week after cholesterol lowering had been achieved. High-cholesterol control mice were injected with PBS. (A) At 40 weeks of age, lesion surface area in mice with low plasma cholesterol (i.e., pI-pC-treated, n = 7) had not progressed and differed significantly from that in high-cholesterol controls at 40 weeks (i.e., PBS-treated, n = 6) (*P<0.005). Figure 1A is shown for comparison; red line indicates mice with low plasma cholesterol. (B-D) One week of low levels of cholesterol (30-week-old mice) did not affect lesion size (P = 0.96), (B) Shown are percent relative changes in lesion area. Figure 1A is shown for comparison; red line indicates the low-cholesterol group. (C) The numbers of foam cells (P = 0.52), endothelial cells (P = 0.49), smooth muscle cells (P = 0.18) (SMC), and T cells (P = 0.34) and (D) the staining of Oil-red-O (upper panels) and fluorescence of anti-rat antibodies binding to rat anti mouse CD68 (lower panels) in representative sections isolated from the aortic root of high-cholesterol (left panels) and low-cholesterol (right panels) mice. Arrows indicate Oil-red-O stained lesions.
###end p 27
###begin p 28
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s027">Text S1</xref>
###xml 481 490 481 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s013">Table S12</xref>
###xml 769 778 769 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3B</xref>
###xml 808 817 808 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3C</xref>
###xml 917 925 917 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s008">Table S7</xref>
###xml 1001 1010 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3D</xref>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
To investigate the molecular mechanisms in the atherosclerotic arterial wall induced by the genetic lowering of plasma cholesterol preventing the formation of advanced lesion, we performed additional gene expression profiling of lesion mRNA isolated from mice sacrificed immediately after plasma cholesterol lowering by Cre-mediated recombination of Mttp in the liver (Text S1). The mRNA levels of thirty-seven atherosclerosis genes responded strongly to the cholesterol lowering (Table S12). To determine if these changes were true changes in cellular mRNA levels or a consequence of changes in lesion size or the relative contributions of cell types, we examined lesion size and the relative numbers of the four major atherosclerosis cell types. Neither lesion size (Figure 3B) nor cell type distribution (Figure 3C) was affected by the subacute lowering of plasma cholesterol, as judged from cell-surface markers (Table S7), Oil-red-O staining, and immunohistochemical analysis of CD68 expression (Figure 3D) suggesting that the observed changes in mRNA levels were true gene activity changes in response to the plasma cholesterol lowering.
###end p 28
###begin p 29
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 60 53 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 49 64 49 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup>Mttp</italic>
###xml 64 73 64 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 426 430 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 439 443 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 443 446 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 457 436 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 457 461 443 447 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</underline>
###xml 446 461 432 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup><underline>Mttp</underline></italic>
###xml 461 466 447 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 461 466 447 452 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>wt/wt</sup></underline>
###xml 470 473 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Although the recombination of Mttp in the Ldlr-/-Apob100/100Mttpflox/floxMx1-Cre mouse leading to lowering of plasma cholesterol mainly takes place in the liver, the intraperitoneal pIhorizontal linepC treatment and the following activation of Cre-recombinase may theoretically in themselves affect gene expression in the atherosclerotic arterial wall. To investigate this possibility, we bred control mice lacking the floxed Mttp allele (Ldlr-/-Apob100/100Mttpwt/wtMx1-Cre) and treated these mice with pI-pC (n = 4) and PBS (n = 5). As expected, the pI-pC treatment had no effect on plasma cholesterol levels (not shown). Moreover, GeneChip analysis of aortic arch mRNA samples from these mice (n = 4+5) showed a low number of differentially expressed genes and none of these were the 37 cholesterol-responsive genes.
###end p 29
###begin title 30
Regulatory Network Identification of Cholesterol Responsive Macrophage Genes
###end title 30
###begin p 31
###xml 205 217 205 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A&#8211;2C</xref>
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s013">Table S12</xref>
###xml 575 582 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 587 594 587 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s027">Text S1</xref>
###xml 760 766 760 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR120</italic>
###xml 792 797 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR81</italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX6</italic>
###xml 1294 1297 1294 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tegner1">[9]</xref>
###xml 1304 1305 1304 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 1339 1340 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 1378 1379 1378 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1454 1455 1454 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The rapid expansion of the lesions between weeks 30 and 40 leading to the formation of advanced plaques was primarily caused by lipid loading of foam cells already present at 30 weeks (clusters 1 and 3 in Figure 2A-2C). We suspected that some of the cholesterol-responsive genes identified at 30 weeks (Table S12) were essential to this process. To address this, total RNA was isolated from targeted and control THP-1 macrophages in cell culture that had been activated by PMA, treated with siRNA or mock and then incubated with acetylated-LDL (AcLDL) for 48 hours (see also Methods and Text S1). Expression data (Affymetrix Hu 130, 2.0+) was generated from 12 siRNA experiments and 4 pools of controls treated with unspecific siRNA (mock). Three transcripts, GPR120 (Entrez Gene ID 338557), GPR81 (Entrez Gene ID 27198) and SOX6 (Entrez Gene ID 55553), were below the detection limits of the GeneChips suggesting that these genes were not active enough in this experimental model of foam cell formation to be detected or inactive. The remaining genes were organized in a 9-by-9 data matrix. Expression data for each gene was normalized by dividing with the mean expression level in controls followed by log-transformation. A linear gene regulation modelwas fit to data as previously described [9]. Here x denotes expression data vectors, W is the network adjacency matrix, and p is the perturbation vector. In each knockdown experiment, the elements of p were -1 for the perturbed gene and 0 for all other genes. Note that because of the log-transform, this corresponds to a multiplicative model in actual expression levels. The algorithm controls the trade off between precision and recall by a single parameter delta. In our experiments we chose delta = 0.2. In simulations we found that this value corresponds to approx. 60% precision and 80% recall. Of note, interactions between genes (i.e. directed edges with stimulating or repressing effect) do not imply direct biological interactions but in most instances indirect (for instances mediated by proteins, metabolites or even intermediate genes (with low expression level such as transcription factors)).
###end p 31
###begin p 32
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAR2B</italic>
###xml 153 162 153 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4A</xref>
###xml 164 171 164 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000036-t002">Table 2</xref>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Nicholson1">[10]</xref>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Hennuyer1">[11]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Hennuyer1">[11]</xref>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL2</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PVRL2</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL2</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 719 724 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARA</italic>
###xml 753 762 753 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4A</xref>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PVRL2</italic>
###xml 856 861 856 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL2</italic>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4A</xref>
###xml 1180 1187 1180 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000036-t003">Table 3</xref>
###xml 1301 1310 1301 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4A</xref>
###xml 1411 1420 1411 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4B</xref>
###xml 501 511 <span type="species:ncbi:138953">poliovirus</span>
PRKAR2B (Entrez Gene ID 5577) had no edges to the other nodes (e.g. genes). The remaining eight nodes were found to belong to a regulatory gene network (Figure 4A, Table 2). These nodes included CD36 (Entrez Gene ID 948), which previously has been shown to promote foam-cell formation [10], and PPARA (Entrez Gene ID 5465) [11], which previously has been shown to prevent it [11]. Hydroxysteroid dehydrogenase-like 2 (HSDL2, Entrez Gene ID 84263) up-regulated PPARA and down-regulated CD36. Moreover, poliovirus receptor-related 2 (PVRL2, Entrez Gene ID 5819) also regulated CD36, increasing its expression and negatively regulating HSDL2 and thus indirectly suppressing PPARA activity. From the regulation of CD36 and PPARA in this regulatory network (Figure 4A), it can be predicted that inhibiting PVRL2 would prevent foam-cell formation and inhibiting HSDL2 would promote it. To validate the network, we tested these predictions by assessing the effect of inhibiting individual genes within the network on cholesterol-ester (CE) and lipid accumulation. The CE accumulations in the THP-1 cells in response to siRNA treatments were in agreement with our predictions (Figure 4A, Table 3). siRNA treatment against several of the other network nodes also affected CE accumulation in THP-1 macrophages (Figure 4A). Representative microscopic images of siRNA treated macrophages stained wit Oil-red-O are shown in Figure 4B.
###end p 32
###begin title 33
A regulatory gene network of foam-cell formation.
###end title 33
###begin p 34
###xml 53 62 53 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s013">Table S12</xref>
###xml 834 841 830 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000036-t003">Table 3</xref>
Twelve cholesterol-responsive atherosclerosis genes (Table S12, in bold) were targeted in THP-1 macrophages using siRNA. Two days after transfection, siRNA-targeted macrophages and controls treated with nonspecific siRNA were incubated with AcLDL (50 microg/mL) for 48 hours; total RNA was isolated, and CE and lipid accumulation were determined. (A) Sixteen expression profiles (HG-U133_Plus_2 arrays, Affymetrix) from 12 siRNA experiments and four pooled controls were used to generate the regulatory gene network (Results) of 8 cholesterol-responsive genes involved in foam-cell formation, including PPARA and CD36. CE accumulation (given as average percentage next to each node) was decreased (blue) by siRNA inhibition of 5 genes and increased (red) by inhibition of 2 genes; inhibition of 1 gene had no effect (black) (see also Table 3). (B) Representative siRNA treated THP-1 cells after 48 incubation with AcLDL and stained with Oil-red-O.
###end p 34
###begin title 35
siRNA inhibition of eight cholesterol-responsive network genes in THP-1 macrophages incubated with acetylated LDL.
###end title 35
###begin p 36
siRNA assays purchased from Ambion.
###end p 36
###begin title 37
Effects of siRNA inhibition of eight cholesterol-responsive network genes on cholesterol-ester accumulation in THP-1 macrophages incubated with acetylated LDL.
###end title 37
###begin p 38
CE, cholesterol ester; nd, no difference; ns, not significant.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 1294 1299 1280 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PVRL2</italic>
###xml 1304 1309 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL2</italic>
In this study, we first used genome-wide expression profiling to identify a point before which atherosclerosis developed slowly and only low-level inflammation was present. After this point, lesions expanded rapidly and inflammation increased markedly. The inflammation persisted in late phases, leading to the formation of advanced plaques, but lesion size increased transiently during a 10-week period. The rapid lesion expansion was primarily caused by an equally rapid lipid accumulation in macrophages. In early lesions, macrophages with low degree of inflammation and low lipid content accumulated. At a certain point, this accumulation halted and was followed by a rapid increase in macrophage lipid content paralleled by an induction of inflammatory genes. Lowering plasma cholesterol at this point prevented the rapid expansion of the lesions and the formation of advanced plaques. The cholesterol-lowering effect was mediated by 37 cholesterol-responsive atherosclerosis genes. Validation of the macrophage-related part of these genes by additional transcriptional profiling of mRNA from siRNA-targeted THP1horizontal linemacrophages incubated with AcLDL exposed a regulatory gene network of foam-cell formation. This network as a whole and some of its individual nodes (particularly PVRL2 and HSDL2) should be considered for therapies to prevent the formation of advanced plaques.
###end p 40
###begin p 41
###xml 81 84 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tuomisto1">[3]</xref>
###xml 794 803 794 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
Transcriptional profiles of atherosclerosis lesions are challenging to interpret [3]. Such lesions contains several cell types, and the average mRNA contribution of a given cell type is altered with disease development. Thus, changes in mRNA levels represent a mixture of actual changes in cellular mRNA concentrations and changes in cell type admixture. In addition, cells in different stages of proliferation and differentiation (e.g., macrophages differentiation into foam cells) adds to this problem also within a given cell type. However, the current lesion mRNA dataset over tight time intervals provides, to our best knowledge, the most comprehensive compendium of lesion expression profiles representing known and novel biological processes and pathways activated during atherogenesis (Figure 2A).
###end p 41
###begin p 42
###xml 34 43 34 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Libby1">[12]</xref>
###xml 1046 1055 1046 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3A</xref>
###xml 771 777 <span type="species:ncbi:9606">humans</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
Analysis of lesion mRNA clusters (Figure 2A) indicated that, at first, macrophages infiltrate the arterial wall, leading to the formation of fatty streaks. Then, at what appears to be a rather specific time point, these cells become activated, leading to a burst of inflammatory activity that, in combination with a rapid accumulation of CE in macrophages, generates advanced plaques; documented as a critical step in atherogenesis [12]. We believe this transformation can be related to the density of macrophages in the arterial wall. At a given density, the macrophages not only stimulate themselves (autocrine) but also stimulate each other (paracrine), leading to a burst of inflammatory activities and increasing lipid uptake. If such a mechanism is also present in humans, the timing of therapies to prevent or slow atherosclerosis development may be very important. Indeed, in these mice, the formation of advanced plaques was all together prevented by genetic lowering of plasma cholesterol immediately before the rapid lesion expansion (Figure 3A).
###end p 42
###begin p 43
###xml 215 227 215 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g003">Figure 3B&#8211;3D</xref>
###xml 512 524 512 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g002">Figure 2A&#8211;2C</xref>
###xml 629 638 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s013">Table S12</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PVRL2</italic>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL2</italic>
###xml 858 863 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PVRL2</italic>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Schmidt1">[13]</xref>
###xml 924 928 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSDL</italic>
###xml 1065 1073 1065 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1073 1077 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Edqvist1">[14]</xref>
In contrast to mRNA profiles isolated during lesion development, the extent and relative composition of different cell types in the lesions were similar before and after the subacute lowering of plasma cholesterol (Figure 3B-3D). Thus, in this case the changes in mRNA concentration monitored by the GeneChips reflect actual changes in cellular mRNA levels. Since the accumulation of lipids in macrophages was a central process in the rapid lesion expansion and formation of advance plaques (clusters 1 and 3 in Figure 2A-2C), we used siRNA in THP-1 macrophages incubated with AcLDL to validate the cholesterol-responsive genes (Table S12). Eight genes were found to belong to a regulatory gene network in which PVRL2 and HSDL2 had central roles. Little is known about PVRL2 and HSDL2 (generating 6 and 3 hits in PubMed, respectively). A sequence variant in PVRL2 is associated with the severity of multiple sclerosis [13]. HSDL encodes the sterol carrier protein-2, a small intracellular basic protein domain that enhances the transfer of lipids between membranes in vitro[14].
###end p 43
###begin p 44
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tegner1">[9]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tegner2">[15]</xref>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000036-g004">Figure 4A</xref>
Although pointing out isolated candidates as being more promising than others is tempting, the lesson from whole-genome approaches will most certainly be that complex diseases like atherosclerosis will not be defeated by targeting single genes (probably not even single regulatory genes) but instead to target several genes belonging to a similar network of pathology [9],[15]. This notion is supported by studying a small gene network as the present (Figure 4A) where none of the nodes (i.e., genes) can be said to solely promote or inhibit foam-cell formation.
###end p 44
###begin p 45
###xml 114 122 <span type="species:ncbi:9606">Patients</span>
Our findings imply that the timing of interventions with plasma cholesterol-lowering agents may be very critical. Patients at risk of developing complications of atherosclerosis (e.g., stroke and MI) may benefit from being treated very early in life. The development of noninvasive technologies to detect early atherosclerosis or molecular markers of atherosclerosis stages will be important in this respect. For normo-cholesterolemic individuals but with other atherosclerosis risk factors, novel regimens targeting atherosclerosis genes that mediate the beneficial effects of plasma cholesterol-lowering may be useful. In summary, the network of cholesterol-responsive atherosclerosis target genes and regulators of foam-cell formation identified in our study merits further attention.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47
###xml 4 9 <span type="species:ncbi:10090">Mouse</span>
The Mouse Model
###end title 47
###begin p 48
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob</italic>
###xml 15 22 15 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 26 35 26 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Lieu1">[7]</xref>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 333 336 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 369 373 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 375 379 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 379 390 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 406 410 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 410 413 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 417 424 397 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100/100</sup>
###xml 413 428 393 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apob<sup>100/100</sup>Mttp</italic>
###xml 428 433 408 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 438 441 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 482 486 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 486 495 466 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
The Ldlr-/-Apob100/100Mttpflox/floxMx1-Cre mouse model has a plasma lipoprotein profile similar to that of familial hypercholesterolemia, which causes rapid progression of atherosclerosis [7]. For Mttp deletion, mice were injected with 500 microl of pI-pC (1 microg/microl; Sigma, St. Louis, MO) every other day for 6 days to induce Cre expression, thereby recombining Mttp (MttpDelta/Delta) or not in the Ldlr-/-Apob100/100Mttpwt/wt Mx1-Cre mice. Littermate controls received PBS (Mttpflox/flox). The study mice had been back crossed 5 times to C57BL/6 (<5% 129/SvJae and >95% C57BL/6), were housed in a pathogen-free barrier facility (12-hour light/12-hour dark cycle), and were fed rodent chow containing 4% fat. Genotypes were determined by polymerase chain reaction (PCR) with genomic DNA from tail biopsies. Plasma cholesterol and triglyceride concentrations were determined in non-fasted blood samples with colorimetric assays (Infinity cholesterol/triglyceride kits; Thermo Electron, Melbourne, Australia), and plasma glucose levels with Precision Xtra (MediScience, Cherry Hill, NJ).
###end p 48
###begin title 49
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">En Face</italic>
En Face Analysis and Histology
###end title 49
###begin p 50
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Veniant1">[16]</xref>
###xml 566 570 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Stotz1">[17]</xref>
###xml 626 629 <span type="species:ncbi:10116">rat</span>
###xml 635 640 <span type="species:ncbi:10090">mouse</span>
###xml 758 761 <span type="species:ncbi:10116">rat</span>
Aortas were pinned out flat on black wax surfaces as described [16], stained with Sudan IV, photographed with a Nikon SMZ1000 microscope, and analyzed with Easy Image Analysis 2000 software (Tekno Optik, Skarholmen, Sweden). Lesion area was calculated as a percentage of the entire aortic surface between the aortic root and the iliac bifurcation. Aortic roots were isolated and immediately frozen in liquid nitrogen in OCT compound (Histolab, Vastra Frolunda, Sweden). Cryosections (20 microm) were cut and stained with hematoxylin (Htx) and Oil-red-O as described [17]; other sections (6-8 microm) were incubated first with rat anti-mouse CD68 antibody or a control antibody (Serotec, Oxford, England) overnight at 4degreesC and then with fluorescent anti-rat IgG (Vector Laboratories, Burlingame, CA) and counterstained with mounting medium containing DAPI (Vector Laboratories).
###end p 50
###begin title 51
Transcriptional Profiling
###end title 51
###begin p 52
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 402 411 402 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 424 435 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;/&#916;</sup>
###xml 443 447 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 447 452 439 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 724 728 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mttp</italic>
###xml 728 733 720 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 527 532 <span type="species:ncbi:10090">Mouse</span>
Aortas were perfused with RNAlater (Qiagen, Valencia, CA), and the aortic arch from above the third rib to the aortic root was removed and homogenized with FastPrep (Qbiogene, Irvine, CA). Total RNA was isolated with RNeasy Mini Kit (Qiagen) using a DNAse I treatment step. RNA quality was assessed with a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). High-quality RNA samples (32 from Mttpflox/flox, 5 from MttpDelta/Delta, and 9 Mttpwt/wt mice) were used for global gene expression measurements with cDNA arrays (Mouse Genome 430 2.0 GeneChips, Affymetrix, Santa Clara, CA) at 10 (n = 7, PBS), 20 (n = 5, PBS), 30 (n = 6, PBS+5, pI-pC), 40 (n = 5), 50 (n = 5), and 60 (n = 4) weeks. In addition at 30 weeks, 9 Mttpwt/wt (n = 5, PBS+4, pI-pC). All samples were prepared with the two-cycle protocol recommended by the manufacturer. Arrays were scanned with GeneChip Scanner 3000 and analyzed with GeneChip Operating Software (Affymetrix).
###end p 52
###begin title 53
Text Mining and Prior Atherosclerosis Knowledge
###end title 53
###begin p 54
###xml 292 307 292 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">atherosclerosis</italic>
###xml 309 325 309 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arteriosclerosis</italic>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s002">Table S1</xref>
###xml 365 374 365 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">foam cell</italic>
###xml 376 386 376 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">macrophage</italic>
###xml 388 396 388 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">monocyte</italic>
###xml 419 427 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s003">Table S2</xref>
###xml 430 448 430 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">smooth muscle cell</italic>
###xml 450 458 450 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s004">Table S3</xref>
###xml 461 477 461 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">endothelial cell</italic>
###xml 479 487 479 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s005">Table S4</xref>
###xml 494 500 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-cell</italic>
###xml 502 510 502 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s006">Table S5</xref>
###xml 778 787 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s001">Figure S1</xref>
###xml 945 953 945 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s007">Table S6</xref>
Automated text mining of PubMed was used to establish lists of genes related to atherosclerosis, foam cells, smooth muscle cells, endothelial cells, and T cells. Briefly, a gene was considered related if it co-occurred with any of the following terms in the abstract of an article in PubMed: atherosclerosis, arteriosclerosis ("atherosclerosis-related", Table S1), foam cell, macrophage, monocyte ("foam cell related", Table S2), smooth muscle cell (Table S3), endothelial cell (Table S4), and T-cell (Table S5). These tables constitute fairly comprehensive but not specific lists of genes with possible roles in atherosclerosis or in the cell types involved in atherosclerosis (i.e., may contain false positives but a low number of false negatives) with a substantial overlap (Figure S1). We also generated a list of "established" atherosclerosis genes by manually extracting from recent reviews genes known to be important in atherosclerosis (Table S6).
###end p 54
###begin title 55
siRNA of THP-1 Macrophages Incubated with Acetylated-LDL
###end title 55
###begin p 56
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 894 898 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Basu1">[18]</xref>
###xml 1104 1108 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Redgrave1">[19]</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 154 158 <span type="species:ncbi:9913">calf</span>
Monocytes of the human monocytic cell line THP-1 were plated in six-well culture dishes (Becton Dickinson Labware, NJ) at 6 x 105 cells/well in 10% fetal calf serum (FCS)-RPMI-1640 medium with L-glutamine (2 mM) and HEPES buffer (25 mM) (Gibco-Invitrogen, Carlsbad, CA) supplemented with penicillin (100 U/mL) and streptomycin (100 microg/mL) (PEST) and induced to differentiate into macrophages with phorbol 12-myristate 13-acetate (PMA) (50 ng/mL) (Sigma) for 72 hours. For each gene, cells were transfected with up to three siRNAs (Ambion, Austin, TX), using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen), in medium without FCS, PEST, and PMA. Two days after transfection, siRNA-targeted macrophages and mock-treated controls (nonspecific siRNA) were incubated with AcLDL (50 microg/mL) for 48 hours in 1% FCS medium with PEST. AcLDL was prepared as described [18]. The samples were dialyzed against PBS at 4degreesC. AcLDL protein concentration was determined by the Bradford method. LDL was isolated from the plasma of healthy donors by sequential ultracentrifugation [19].
###end p 56
###begin title 57
Lipid, Protein, and Gene Expression Measurements
###end title 57
###begin p 58
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Christoffersen1">[20]</xref>
For lipid imaging, THP-1-derived foam cells were fixed with 10% formaldehyde in PBS for 10 min and washed twice with PBS. The cells were stained with Oil-red-O (0.3% in 60% isopropanol) for 20 min, washed twice with 60% isopropanol and twice with PBS, and examined with a Nikon Eclipse E800 microscope at 40x magnification. Lipids were isolated by hexan/isopropanol (3:2) extraction at room temperature for 1 hour followed by 0.5 ml chloroform for 15 min [20]. The lipid extracts were dried and resuspended in 80 microl of isopropanol with 1% Triton-X-100 (Sigma). The lipid content of the foam cells was determined by enzymatic assays using the Infinity kit for total cholesterol (Thermo Electron) and a kit for free cholesterol (Wako Chemicals, Richmond, VA). After lipid extraction, proteins were extracted from the same wells by incubation with 0.5 M sodium hydroxide for 5 hours at 37degreesC. Protein concentration was determined by the Bradford method.
###end p 58
###begin p 59
###xml 894 901 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s027">Text S1</xref>
For HG-U133_Plus_2 array analysis (Affymetrix) and to determine the degree of knockdown by siRNA, total RNA was isolated from the AcLDL-incubated THP-1 cells with RNeasy Mini-kit (Qiagen). The concentration was determined with a spectrophotometer (ND-100, NanoDrop Technologies, Wilmington, DE). For cDNA synthesis, 0.5 microg of total RNA was reverse transcribed with Superscript II (Invitrogen) according to the manufacturer's protocol. After 5-fold dilution, cDNA (3 microL) was amplified by real-time PCR with 1xTaqMan universal PCR master mix (Applied Biosystems, Foster City, CA) on an ABI Prism 7000 (PE Biosystems) and software according to the manufacturer's protocol. Assay-On-Demand Kits containing corresponding primers and probes from Applied Biosystems were used, and expression values were normalized to acidic ribosomal phosphoprotein P0. Each sample was analyzed in duplicate (Text S1).
###end p 59
###begin title 60
Statistics and Calculations
###end title 60
###begin p 61
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Cleveland1">[21]</xref>
###xml 1156 1159 1156 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Efron1">[8]</xref>
###xml 1329 1333 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Hosack1">[22]</xref>
###xml 1431 1434 1431 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000036-Tegner1">[9]</xref>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 403 408 <span type="species:ncbi:10090">Mouse</span>
###xml 574 579 <span type="species:ncbi:10090">Mouse</span>
Differences in the mRNA levels of selected genes, mouse plasma measurements, and lesion surface areas between time points were analyzed with unpaired t tests. Gene expression signal-level data were computed with MAS 5.0 (Affymetrix) using default settings, log-transformed, and normalized to total intensities (global scaling). After normalization, signal intensities were computed for each gene in the Mouse Genome Informatics Database (MGD genes, Jackson Laboratory, ) by averaging the signal of the corresponding Affymetrix probe sets. Of the 11,979 GeneChip probe sets (Mouse Genome 430 2.0 GeneChips, Affymetrix) that had no match in the database, 1.5% were differentially expressed (false discover rate (FDR) <0.05, n = 177), representing the fraction of genes/probe sets that were not considered for further analyses. The remaining 33,122 probe sets had at least one match in 19,879 MGD genes (of a total of 32,095). Lowess normalization [21] was applied in pair-wise fashion before differential expression testing. To correct for multiple testing when computing probabilities of differential expression and FDRs, we used empirical Bayes statistics [8]. Clustering was performed with the FindCluster algorithm in Mathematica 5.1 (Wolfram Research, Champaign, IL). GO and pathway analyses were performed with EASE software [22]. The regulatory gene network of THP-1 macrophages incubated with AcLDL was inferred as described [9].
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
###xml 52 61 52 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s003">Tables S2</xref>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s004">S3</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s005">S4</xref>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000036.s006">S5</xref>
Relations between the cell-type textmining lists in Tables S2, S3, S4, and S5
###end p 63
###begin p 64
(0.36 MB EPS)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
Textmining list, Atherosclerosis
###end p 66
###begin p 67
(0.24 MB XLS)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
Textmining list, Macrophages
###end p 69
###begin p 70
(0.32 MB XLS)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Textmining list, Smooth muscle cells (SMCs).
###end p 72
###begin p 73
(0.30 MB XLS)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Textmining list, Endothelial cells
###end p 75
###begin p 76
(0.22 MB XLS)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
Textmining list, T-cells
###end p 78
###begin p 79
(0.37 MB XLS)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
List of established atherosclerosis genes with t-test p-values
###end p 81
###begin p 82
(0.03 MB XLS)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
Cell-specific markers.
###end p 84
###begin p 85
(0.02 MB XLS)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
Gene list, lesion cluster 1
###end p 87
###begin p 88
(0.06 MB XLS)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
Gene list, lesion cluster 2
###end p 90
###begin p 91
(0.06 MB XLS)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
Gene list, lesion cluster 3
###end p 93
###begin p 94
(0.06 MB XLS)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
Gene list, lesion cluster 4
###end p 96
###begin p 97
(0.05 MB XLS)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
List of 37 cholesterol-responsive genes.
###end p 99
###begin p 100
(0.03 MB XLS)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
GO analysis, lesion cluster 1
###end p 102
###begin p 103
(0.21 MB XLS)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
GO analysis, lesion cluster 2
###end p 105
###begin p 106
(0.15 MB XLS)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
GO analysis, lesion cluster 3
###end p 108
###begin p 109
(0.17 MB XLS)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
GO analysis, lesion cluster 4
###end p 111
###begin p 112
(0.13 MB XLS)
###end p 112
###begin p 113
Click here for additional data file.
###end p 113
###begin p 114
KEGG and Biocarta pathway analysis, lesion cluster 1
###end p 114
###begin p 115
(0.01 MB XLS)
###end p 115
###begin p 116
Click here for additional data file.
###end p 116
###begin p 117
KEGG and Biocarta pathway analysis, lesion cluster 2
###end p 117
###begin p 118
(0.01 MB XLS)
###end p 118
###begin p 119
Click here for additional data file.
###end p 119
###begin p 120
KEGG and Biocarta pathway analysis, lesion cluster 3
###end p 120
###begin p 121
(0.01 MB XLS)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin p 123
KEGG and Biocarta pathway analysis, lesion cluster 4
###end p 123
###begin p 124
(0.01 MB XLS)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
KEGG and Biocarta pathway analysis, all genes
###end p 126
###begin p 127
(0.01 MB XLS)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin p 129
Transcription factors in lesion cluster 1
###end p 129
###begin p 130
(0.02 MB XLS)
###end p 130
###begin p 131
Click here for additional data file.
###end p 131
###begin p 132
Transcription factors in lesion cluster 2
###end p 132
###begin p 133
(0.01 MB XLS)
###end p 133
###begin p 134
Click here for additional data file.
###end p 134
###begin p 135
Transcription factors in lesion cluster 3
###end p 135
###begin p 136
(0.02 MB XLS)
###end p 136
###begin p 137
Click here for additional data file.
###end p 137
###begin p 138
Transcription factors in lesion cluster 4
###end p 138
###begin p 139
(0.01 MB XLS)
###end p 139
###begin p 140
Click here for additional data file.
###end p 140
###begin p 141
Supporting Methods
###end p 141
###begin p 142
(0.03 MB DOC)
###end p 142
###begin p 143
Click here for additional data file.
###end p 143
###begin p 144
###xml 99 103 <span type="species:ncbi:10090">mice</span>
We thank Professor Stephen G. Young (University of California, Los Angeles) for help providing the mice.
###end p 144
###begin title 145
References
###end title 145
###begin article-title 146
###xml 84 91 <span type="species:ncbi:9606">patient</span>
The statin studies: from targeting hypercholesterolaemia to targeting the high risk patient.
###end article-title 146
###begin article-title 147
The role of statins in reversing atherosclerosis: What the latest regression studies show.
###end article-title 147
###begin article-title 148
Genetics, genomics and proteomics in atherosclerosis research.
###end article-title 148
###begin article-title 149
###xml 20 25 <span type="species:ncbi:9606">human</span>
The sequence of the human genome.
###end article-title 149
###begin article-title 150
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome.
###end article-title 150
###begin article-title 151
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Initial sequencing and comparative analysis of the mouse genome.
###end article-title 151
###begin article-title 152
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion.
###end article-title 152
###begin article-title 153
Empirical Bayes analysis of a microarray experiment.
###end article-title 153
###begin article-title 154
Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling.
###end article-title 154
###begin article-title 155
Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis.
###end article-title 155
###begin article-title 156
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
###end article-title 156
###begin article-title 157
Macrophages and atherosclerotic plaque stability.
###end article-title 157
###begin article-title 158
Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis.
###end article-title 158
###begin article-title 159
Fusion and fission, the evolution of sterol carrier protein-2.
###end article-title 159
###begin article-title 160
Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits.
###end article-title 160
###begin article-title 161
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
###end article-title 161
###begin article-title 162
Oil red O: Comparison of staining quality and chemical components as determined by thin layer chromatography.
###end article-title 162
###begin article-title 163
Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
###end article-title 163
###begin article-title 164
###xml 148 151 <span type="species:ncbi:9606">man</span>
Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man.
###end article-title 164
###begin article-title 165
###xml 34 39 <span type="species:ncbi:9606">human</span>
Isolation and characterization of human apolipoprotein M-containing lipoproteins.
###end article-title 165
###begin article-title 166
Robust locally weighted regression and smoothing scatterplots.
###end article-title 166
###begin article-title 167
Identifying biological themes within lists of genes with EASE.
###end article-title 167
###begin p 168
Johan Bjorkegren and Jesper Tegner are stock owners in Clinical Gene Networks AB. The company has filed a provisional patent on the atherosclerosis gene network presented in this study.
###end p 168
###begin p 169
This work was supported by grants from the Swedish Research Council (JB), the Karolinska Institute (JB, AH), the Stockholm County Council (JB, AH), the Swedish Heart-Lung Foundation (JB), the King Gustaf V and Queen Victoria Foundation (JB), the Swedish Society of Medicine (JB, JT), the Hans and Loo Osterman Foundation for Geriatric Research (JS, JB), the National Network for Cardiovascular Disease (JS), the Professor Nanna Swartz Fund (JB), the Foundation for Old Servants (JB), and the Magnus Bergvalls Foundation (JB), the Ake Wiberg Foundation (JB, JT), the Wennergren Foundation (JT), the Swedish Foundation for Strategic Research (JB, JT), the PhD Programme in Medical Bioinformatics (JB, JT) at Linkoping University, and European Commission FP6 (contract: LSHM-CT-2007-037273) (JB, AH).
###end p 169

